Immune to Cancer: The CRI Blog
-
Before Cancer Takes Hold: The Science of Cancer Interception
For the first time, CLIP applications will focus on a designated scientific theme: primary and secondary cancer prevention and interception…. -
It Takes a Village to Carry Cancer
Everybody thinks about the actual cancer patient. They don’t always think about the number of people who… -
A New Milestone for Cancer Vaccines — Decades in the Making
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a patient’s immune… -
Can Viruses Fight Cancer? What Tudriqev Means for Patients With Melanoma
The U.S. Food and Drug Administration’s (FDA) accelerated approval of Tudriqev marks FDA’s first new approval of… -
Meet the 2026 STARs: Aaron Whiteley, PhD
I’m a microbiologist who’s passionate about immune signaling. Meet Aaron Whiteley, PhD, an Assistant Professor in the… -
The Future Starts Here: Meet the 2025–2026 Postdoctoral Fellows
Tomorrow’s breakthroughs in cancer immunotherapy begin with today’s early-career scientists. By investing in promising researchers at the… -
Why Is Lung Cancer Rising in Nonsmokers?
For decades, lung cancer has been closely associated with smoking — and for good reason. Smoking remains… -
From Bold Ideas to Breakthroughs: Introducing CRI’s 2026 CLIP & Technology Impact Award Projects
What if the next advance in cancer immunotherapy starts with one bold idea? Every breakthrough begins with… -
What Patients Should Know About Sarcoma and Immunotherapy
Sarcoma is rare and complex. Immunotherapy isn’t yet an option for everyone — but it’s changing what’s…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.